Summaries for patients. Can a new antibiotic safely prevent travelers' diarrhea?
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D003967:Diarrhea / Q000382:microbiology / Q000517:prevention & control*; D004927:Escherichia coli Infections / Q000517:prevention & control*; D006801:Humans; D007408:Intestinal Absorption; D008800:Mexico; D012294:Rifamycins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000078262:Rifaximin; D014195:Travel; D016896:Treatment Outcome; D014481:United States
D000900:Anti-Bacterial Agents; D012294:Rifamycins; D000078262:Rifaximin